中国医药导报
中国医药期刊欢迎您 今天是   2025年4月8日星期二
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报  2023, Vol. 20 Issue (35): 119-123,153    DOI: 10.20047/j.issn1673-7210.2023.35.26
  临床医学-肿瘤 本期目录 | 过刊浏览 | 高级检索 |
中药热奄包对单侧甲状腺癌患者术后康复的临床研究
孙 康1  汪晓明1  王建国2  马朝群3
1.安徽中医药大学第一附属医院普外科,安徽合肥 230031;
2.中国科学技术大学第一附属医院肿瘤科,安徽合肥 230001;
3.南京中医药大学附属医院 江苏省中医院普外科,江苏南京 210029
Clinical study of traditional Chinese medicine Reyanbao to accelerate pos- toperative rehabilitation unilateral thyroid cancer patients
SUN Kang1 WANG Xiaoming1 WANG Jianguo2 MA Chaoqun3
1.Department of General Surgery, the First Affiliated Hospital of Anhui University of Chinese Medicine, Anhui Province, Hefei 230031, China;
2.Department of Oncology, the First Affiliated Hospital of University of Science and Technology of China, Anhui Province, Hefei 230001, China;
3.Department of General Surgery, Affiliated Hospital of Nanjing University of Chinese Medicine Jiangsu Province Hospital of Chinese Medicine, Jiangsu Province, Nanjing 210029, China
全文: PDF (1097 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨中药热奄包对于单侧甲状腺癌患者术后康复的临床疗效。 方法 选取2017年2月至2021年11月在安徽中医药大学第一附属医院普外科接受单侧甲状腺癌手术治疗的患者92例,按照随机抛硬币法分为观察组(43例)和对照组(49)例。对照组实施甲状腺癌术后常规护理及常规对症处理;观察组在对照组治疗的基础上联合中药热奄包治疗。比较两组临床疗效;比较两组术后连续3 d头痛及颈肩背部肌肉酸痛视觉模拟评分法(VAS)评分;比较两组术后连续3 d颈部引流液量;比较两组术后第3天促甲状激素(TSH)水平。结果 观察组临床疗效优于对照组,差异有统计学意义(P<0.05)。观察组术后第1、2、3天VAS评分、颈部引流液低于对照组,差异有统计学意义(P<0.05);两组各时间点VAS评分、颈部引流液比较,差异有统计学意义(P<0.05)。两组术后第3天TSH水平比较,差异无统计学意义(P>0.05)。 结论 中药热奄包可以通过穴位及局部渗透的作用明显缓解单侧甲状腺癌术后患者颈肩背部肌肉酸痛、头晕、头痛、恶心、呕吐、颈部肿胀等不适症状,同时能够明显减少颈部创面的渗出,降低引流液量,加速术后康复,具有显著临床疗效。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
孙 康1  汪晓明1  王建国2  马朝群3
关键词 中药热奄包甲状腺癌术后康复临床研究    
Abstract:Objective To explore the clinical efficacy of traditional Chinese medicine Reyanbao on postoperative rehabilitation of unilateral thyroid cancer patients. Methods This study was conducted on 92 patients who underwent surgical treatment for unilateral thyroid cancer at the Department of General Surgery, the First Affiliated Hospital of Anhui University of Chinese Medicine from February 2017 to November 2021. The patients were assigned into the observation group (43 ceses) and the control group (49 cases) by random coin toss method. The control group received routine nursing and routine symptomatic treatment after thyroid cancer operation. On the basis of the treatment in the control group, the observation group was also treated with traditional Chinese medicine Reyanbao. The clinical effect of the two groups was compared. The visual analogue scale (VAS) scores of headache and neck, shoulder and back muscle soreness for three consecutive days after operation were compared between the two groups. The volume of neck drainage for three consecutive days after operation was compared between the two groups. The levels of thyroid-stimulating hormone (TSH) on day 3rd after operation were compared between the two groups.Results The clinical efficacy of the observation group was better than that of the control group, and the difference was statistically significant (P<0.05). VAS scores and neck drainage in the observation group were lower than those in the control group at day 1, 2 and 3 after operation, the differences were statistically significant(P<0.05). There were significant differences in VAS scores and neck drainage between the two groups at each time point (P<0.05). There was no significant difference in TSH level between the two groups on the 3rd day after surgery (P>0.05). Conclusion Traditional Chinese medicine Reyanbao can significantly relieve the discomfort symptoms of neck, shoulder and back muscular soreness, dizziness, headache, nausea, and vomiting, neck swelling and other discomfort symptoms of patients with unilateral thyroid cancer after surgery through the effect of acupoints and local penetration. At the same time, it can markedly reduce the exudation of neck wounds, lower the amount of drainage fluid, accelerate postoperative rehabilitation, and has outstanding clinical efficacy.
Key wordsTraditional Chinese medicine Reyanbao    Thyroid cancer    Postoperative rehabilitation    Clinical study
    
基金资助:江苏省自然科学基金面上项目(BK20181506)。
通讯作者: 马朝群(1964-),男,博士,主任医师,博士生导师,南京中医药大学附属医院副院长;研究方向:中医药治疗普外科疾病的临床与学术研究。   
作者简介: 孙康(1987-),男,南京中医药大学第一临床医学院2022级中医外科学专业在读博士研究生;研究方向:中医药治疗普外科疾病的临床与学术研究。
引用本文:   
孙 康1  汪晓明1  王建国2  马朝群3. 中药热奄包对单侧甲状腺癌患者术后康复的临床研究[J]. 中国医药导报, 2023, 20(35): 119-123,153.
SUN Kang1 WANG Xiaoming1 WANG Jianguo2 MA Chaoqun3. Clinical study of traditional Chinese medicine Reyanbao to accelerate pos- toperative rehabilitation unilateral thyroid cancer patients. 中国医药导报, 2023, 20(35): 119-123,153.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/10.20047/j.issn1673-7210.2023.35.26     或     https://www.yiyaodaobao.com.cn/CN/Y2023/V20/I35/119

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司